mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Título
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Autor
Tiago Azenha Rama, André Moreira, Mariana Castells
Fecha
2021
Identificador
10.1016/j.jaci.2021.01.004
Fuente
The Journal of allergy and clinical immunology
Archivos
Colección
Citación
Tiago Azenha Rama, André Moreira, Mariana Castells, “mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.,” SOCICT Open, consulta 10 de junio de 2026, https://www.socictopen.socict.org/items/show/8564.
Position: 5696 (37 views)